Panel Discussion: Building Stronger Bridges Between Biotechs, Pharma & Investors

• Share how biotechs can present data and strategy in ways that help investors and pharma make faster, more confident decisions, reducing risk on both sides
• Highlight how pharma and investors can communicate expectations more clearly ensuring companies design studies and pipelines that are partner-ready

Speakers:

Mark Exley

Chief Scientific Officer

Lift Biosciences

Michal Golan Mashiach

Chief Executive Officer

Edity Therapeutics

Semra Kitchen

Senior Director, Search & Evaluation R&I

AstraZeneca